Sanofi sues Sarep­ta, al­leg­ing that Duchenne treat­ment Ele­v­idys in­fringes on AAV patents

Sanofi is su­ing Sarep­ta Ther­a­peu­tics, al­leg­ing that the com­pa­ny’s ap­proved mus­cu­lar dy­s­tro­phy treat­ment in­fringes on its patents re­lat­ed to the chem­i­cal make­up of the prod­uct …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER